Preparation method and application of composite porous hydrogel microspheres based on sequential temperature control

Through sequential temperature control technology, gelatin and chitosan are modified, combined with photocuring and gradient freezing, the problem of hydrogel microsphere size control is solved, and composite microspheres with good biocompatibility and cell adsorption ability are prepared. cultured in biological scaffolds and cells.

CN119081216APending Publication Date: 2024-12-06NORTHEAST AGRICULTURAL UNIVERSITY
View PDF 0 Cites 1 Cited by

Patent Information

Application Number
CN202411198770.1
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-29
Publication Date
2024-12-06

AI Technical Summary

Technical Problem

The prior art is difficult to regulate the inefficient dissolution of chitosan and the inability to achieve uniform mixing of gelatin and chitosan when preparing microcarriers, resulting in difficult control of the size of hydrogel microspheres.

Method used

Using the preparation method of composite porous hydrogel microspheres based on sequential temperature control, transparent, uniform surface pores and degradable microspheres are prepared by modifying gelatin and chitosan, combining photoinitiators and emulsifiers, gradient freezing technology is used to prepare transparent, uniform surface pores and degradable microspheres. The ball controls the particle size and surface roughness of the microspheres and enhances the cell adsorption capacity.

Benefits of technology

A uniform mixing of gelatin and chitosan is achieved, and composite hydrogel microspheres with adjustable size are obtained, with good biocompatibility and cell adsorption ability, suitable for biological scaffolding and cell culture, promoting angiogenesis and osteogenesis Differentiation.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119081216A_ABST
    Figure CN119081216A_ABST
Patent Text Reader

Abstract

The invention discloses a preparation method and application of composite porous hydrogel microspheres based on sequential temperature control, and belongs to the technical field of crossing of biological materials and cell culture. In order to solve the technical problems that chitosan is not easy to dissolve and the size of hydrogel microspheres cannot be regulated and controlled when a microcarrier is prepared, methacrylic anhydride modified gelatin and methacrylic anhydride modified chitosan are dissolved in 1 * PBS containing a photoinitiator, an emulsifier is added to obtain a pre-polymerized solution, the emulsifier is dissolved in paraffin oil, and the pre-polymerized solution is added to prepare the hydrogel microspheres. An oil phase solution containing 0.1%-0.4% of the emulsifying agent is obtained; the preparation method comprises the following steps: adding a pre-polymerization solution into an oil phase solution, dropwise adding the pre-polymerization solution into the oil phase solution at a speed of 0.1-1mL / min, stirring to obtain a W / O emulsion, exposing for 30s-5min under 405nm blue light at an illumination intensity of 100mw / cm < 2 >, carrying out photocuring to obtain hydrogel microspheres, and freezing to obtain the porous hydrogel microspheres, thereby providing more choices for 3D culture of cells.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention belongs to the cross-technical field of biomaterials and cell culture, and in particular relates to a preparation method and application of composite porous hydrogel microspheres based on sequential temperature control. Background Art

[0002] Compared with the traditional two-dimensional (2D) culture method, three-dimensional (3D) cell culture is closer to the real tissue structure and complex interactions between cells in the body, thus providing researchers with a more accurate simulation platform for the microenvironment in the body. In the process of studying cell behavior, the 3D culture model is significantly better than the 2D culture. It can more accurately show the dynamic process of cell migration and deeply reveal the synergistic mechanism between cells. In addition, 3D culture technology can effectively reduce the damage to cells during in vitro culture, thereby greatly improving the survival rate of cells and maintaining better biological activity and physiological state of cells. 3D cell culture is highly operable and can provide a more suitable growth environment for different cells according to their survival needs. At present, a variety of three-dimensional cell culture methods have emerged, such as forced floating method, stirring method and scaffold method. 3D cell culture has broad application prospects in biology and medicine, which not only provides new strategies and means for clinical treatment, but also opens up new directions for scientific research.

[0003] Hydrogels are biodegradable and biocompatible, and can be used to mimic the key features of natural extracellular matrix, thereby promoting cell proliferation and differentiation and tissue regeneration, and ultimately achieving the repair and reconstruction of damaged tissues. Gelatin, hyaluronic acid, and collagen are all good hydrogel scaffold materials that can be used for drug delivery, promoting angiogenesis, and bone repair. Gelatin, as a pH-sensitive natural polymer protein, is widely used due to its biocompatibility, non-immunogenicity, and low cost. Its arginine-glycine-aspartic acid (RGD) sequence and matrix metalloproteinase (MMP)-sensitive sites can promote cell binding and support cell proliferation. In addition, microspheres (GMSs) prepared using gelatin as a basic material can be used as efficient carriers for drug or cell delivery. However, gelatin has a slow degradation rate and poor mechanical properties, which makes the use of gelatin to prepare hydrogel bioscaffolds that need to maintain stable morphology and excellent mechanical properties face many difficulties and challenges. Chitosan is derived from chitin and is a natural alkaline cationic polymer. Positively charged bioscaffolds prepared using chitosan can better attract cell adhesion and are conducive to cell adhesion and proliferation. Chitosan has natural advantages in the preparation of sustained-release materials and drug carriers, but its molecular structure contains a large number of hydroxyl (-OH) and amino (-NH2) active groups, which easily form hydrogen bonds and make it poorly water-soluble and insoluble in most organic solvents, greatly limiting the application of chitosan.

[0004] In existing research, gelatin and chitosan have been used together to prepare biological scaffolds to improve the performance of the scaffolds. However, due to the fact that chitosan is extremely insoluble and the solidification points of gelatin and chitosan are different, it is impossible to evenly mix gelatin and chitosan in most studies. The advantages of the two are mostly integrated by layered cross-linking, which cannot fully bring out the advantages of the composite. In addition, studies have found that spherical hydrogels have a larger specific surface area than block hydrogels in conventional shapes, and their size is small, which is more conducive to micro-assembly. The stirring method is the most common method for preparing hydrogel microspheres. It is simple to operate, has low instrument requirements, and is easy to mass produce. However, in the process of preparing microcarriers using the stirring method, the controllability is poor, the size and dispersibility of the droplets are affected by the degree and time of mixing, and it is difficult to control the size of the microspheres. The amount of emulsifier, the optimal temperature and time of each stage still need to be further explored. Summary of the invention

[0005] The invention aims to solve the technical problem that chitosan is not easy to dissolve and the size of hydrogel microspheres cannot be regulated when preparing microcarriers.

[0006] The present invention provides a method for preparing composite porous hydrogel microspheres based on sequential temperature control, and the specific steps of the preparation method are as follows:

[0007] Step 1: Weigh 0.2-0.4 g of methacrylic anhydride-modified gelatin and dissolve it in 2 mL-4 mL of 1×PBS containing 0.5%-2% by volume of photoinitiator to obtain a gelatin solution with a final concentration of 10%-20%;

[0008] Step 2: Weigh 0.01 g to 0.02 g of methacrylic anhydride-modified chitosan and dissolve it in 1 mL to 2 mL of 1×PBS containing 0.5% to 2% by volume of a photoinitiator to obtain a chitosan solution with a final concentration of 1% to 2%;

[0009] Step 3: placing the gelatin solution obtained in step 1 and the chitosan solution obtained in step 2 in a 37-50° C. water bath away from light and mixing to obtain a mixed solution;

[0010] Step 4: dissolving 0.01 g to 0.1 g of an emulsifier in the mixed solution obtained in step 3 to obtain a prepolymer solution;

[0011] Step 5: Dissolve 0.06 g to 0.24 g of the emulsifier in 15 mL to 60 mL of paraffin oil to obtain an oil phase solution containing 0.1% to 0.4% Span-80;

[0012] Step 6: Slowly drip the prepolymer solution obtained in step 4 into the oil phase solution obtained in step 5 at a rate of 0.1-1 mL / min, and stir at 400-1000 rpm in the dark for 30-60 min at 20-22°C to obtain a W / O emulsion with a concentration of 100 mw / cm 2 The light intensity was set to 405 nm, and the resulting gelatin microspheres were exposed to 405 nm blue light for 30 s to 5 min for photocuring.

[0013] Step 7: Degrease the microspheres obtained in step 6, freeze them at -20°C for 0-30 min, then move them to -80°C for 0-10 min, and finally quickly freeze them in liquid nitrogen for 5-10 min for gradient freezing, and freeze-dry them to obtain gelatin-chitosan composite porous hydrogel microspheres.

[0014] It is further defined that the method for obtaining methacrylic anhydride modified gelatin in step 1 is as follows:

[0015] (1) Weigh 10 g of gelatin and dissolve it in 100 mL of 1× PBS;

[0016] (2) Stirring at 400 rpm for 30 min at 50 °C to accelerate dissolution;

[0017] (3) Slowly add 5 mL of methacrylic anhydride and react for 2 h;

[0018] (4) Pour the reaction solution into a dialysis bag with a molecular weight cutoff of 14 kDa and dialyze at 40 °C for 7 days;

[0019] (5) The dialyzed gelatin is freeze-dried to obtain modified gelatin.

[0020] It is further defined that the method for obtaining methacrylic anhydride modified chitosan in step 2 is as follows:

[0021] (1) Weigh 1.5 g of chitosan and dissolve it in 100 mL of 4% (v / v) glacial acetic acid;

[0022] (2) Stir at room temperature for 12 h to accelerate dissolution;

[0023] (3) Slowly add 6 mL of methacrylic anhydride and stir at 400 rpm for 12 h at 40 °C in the dark;

[0024] (4) Pour the reaction solution into a dialysis bag with a molecular weight cutoff of 14 kDa and dialyze at 40 °C for 7 days;

[0025] (5) The dialyzed chitosan is freeze-dried to obtain modified chitosan.

[0026] It is further defined that the photoinitiator is LAP.

[0027] It is further defined that the emulsifiers are Tween-60 and Span-80.

[0028] It is further defined that the degreasing treatment method in step 7 is to add 5 mL of acetone and wash three times.

[0029] The invention provides a gelatin-chitosan composite porous hydrogel microsphere obtained by the above preparation method.

[0030] The present invention provides an application of the above-mentioned gelatin-chitosan composite porous hydrogel microspheres in the preparation of biological scaffolds for purposes other than diagnosis and treatment.

[0031] The present invention provides an application of the gelatin-chitosan composite porous hydrogel microspheres in cultured cells for purposes other than diagnosis and treatment.

[0032] The present invention provides an application of the gelatin-chitosan composite porous hydrogel microspheres in promoting angiogenesis or promoting osteogenic differentiation for purposes other than diagnosis and treatment.

[0033] The modification is divided into four stages: dissolution stage, modification stage, purification stage and freeze-drying stage. The microsphere preparation is divided into four stages: dissolution stage, emulsification stage, solidification stage and gradient freezing stage. The above eight stages all have temperature control to form sequential temperature control.

[0034] The present invention provides a method for modifying gelatin and chitosan, comprising the following steps:

[0035] S1, dissolution stage: gelatin and chitosan are dissolved under stirring, wherein gelatin is dissolved in 1×PBS at a dissolution temperature of about 4-50°C, preferably about 50°C, and a dissolution time of about 20-40 min, preferably about 30 min. Chitosan is dissolved in glacial acetic acid at a concentration of 1-10% (v / v), preferably in 4% (v / v) glacial acetic acid, at a dissolution temperature of about 4-50°C, preferably about 23°C, and a dissolution time of about 12-48 h, preferably 12 h.

[0036] S2, modification stage: slowly drip methacrylic anhydride into the S1 solution, stir in the dark, and keep the temperature at 37-50°C, preferably 40°C. The reaction time of gelatin solution is 1-12h, preferably 2h. The reaction time of chitosan solution is 12-48h, preferably 12h.

[0037] S3, purification stage: the solution obtained in S2 is purified, preferably by dialysis, with the dialysis temperature being 37-50°C, preferably about 40°C.

[0038] S4, freeze-drying stage: freeze-dry the solution obtained in S3 for 3-7 days, preferably about 5 days, to obtain modified gelatin and chitosan.

[0039] The present invention provides a method for preparing the above-mentioned gelatin-chitosan porous hydrogel microspheres, comprising the following steps:

[0040] S1, dissolution stage: the freeze-dried material is dissolved in PBS, preferably at a dissolution temperature of 50°C, and a photoinitiator is added.

[0041] S2, emulsification stage: gelatin and chitosan solution are prepared into prepolymer solution according to the proportion, emulsifier is added, and the solution is fully dissolved in a water bath, preferably at 50° C. The prepolymer solution is slowly dripped into the oil phase containing the emulsifier, stirred in the dark, and the ambient temperature is 19-25° C., preferably 20-22° C.

[0042] S3, curing stage: the collected W / O emulsion is subjected to light curing treatment, and the microspheres are cleaned.

[0043] S4, gradient freezing stage: the microspheres are placed in -20°C, -80°C and liquid nitrogen for gradient freezing, and freeze-dried to obtain porous microspheres.

[0044] Beneficial effects: First, the composite hydrogel microspheres are transparent, have uniform surface pores, are degradable, have good biocompatibility, and can support cell proliferation and adhesion. Figure 6 Figure 7 All are supported by biocompatibility data.

[0045] Secondly, the microspheres combine the advantages of gelatin and chitosan, especially the positive charge property carried on the surface of chitosan, which further enhances the microspheres' ability to adsorb cells. The cell adsorption effect can be observed in the fluorescence image.

[0046] On the third aspect, by adjusting the amount of emulsifier used in the preparation process, the particle size of the microspheres can be controlled to be tens to hundreds of microns to adapt to different tissue engineering needs. In addition, the present invention combines gradient freezing technology to give the microspheres a porous structure, increase the surface roughness and specific surface area of ​​the microspheres, and thus provide an ideal microenvironment for cell adhesion and growth. Controlling the size can adapt the microspheres to different tissue engineering needs, and microspheres of different sizes can be selected according to the different environments used. The control of size depends on the amount of emulsifier used and the ambient temperature during stirring. Large size refers to the absence of emulsifier, and only by changing the stirring temperature, the microsphere diameter is between 150-350μm, and small size refers to the addition of emulsifiers, and by controlling the temperature, the microsphere diameter is between 30-60μm, and the emulsifiers are Tween-60 and Span-80, and paraffin oil is to provide an oil phase environment.

[0047] Fourthly, the microspheres can effectively promote angiogenesis and have potential application prospects in promoting osteogenic differentiation. The MC3T3-E1 cells used in the examples are mouse embryonic osteoblast precursor cells. Currently, the microspheres can support the growth of the cells and promote cell proliferation.

[0048] The material is modified, the size of the microspheres is controlled by adjusting the amount of emulsifier, and sequential temperature control is implemented to achieve the mutual fusion of the composite materials, thereby obtaining size-adjustable homogeneous composite hydrogel microspheres. The stirring method is to place the water phase in the oil phase and disperse the water phase into small droplets through physical stirring. The oil phase is later washed and removed to obtain microcarriers. Paraffin oil is used to provide an oil phase environment. BRIEF DESCRIPTION OF THE DRAWINGS

[0049] Figure 1 Schematic diagram of the preparation process of gelatin-chitosan porous hydrogel microspheres;

[0050] Figure 2 The optical microscope images and particle size distribution of the prepared microspheres are shown in Figures A and B. The optical microscope images of the microspheres of Example 1, Example 2 and Example 3 are shown in Figures B and B. The particle size distribution of the microspheres of Example 1, Example 2 and Example 3 are shown in Figures A and B.

[0051] Figure 3 Optical microscope images of microspheres before pores were made and after pores were made and rehydrated;

[0052] Figure 4 A: scanning electron microscope images of microspheres after pore formation; A: optical microscope images of microspheres in Example 1, Example 2 and Example 3; B: particle size distribution of microspheres in Example 1, Example 2 and Example 3;

[0053] Figure 5 Fluorescence microscopy images of microspheres loaded with different types of cells;

[0054] Figure 6 This is a live-death staining image of HUVEC cells seeded on the surface of gelatin-chitosan porous hydrogel microspheres;

[0055] Figure 7 This is a graph showing the cell proliferation activity of HUVEC seeded on the surface of gelatin-chitosan porous hydrogel microspheres;

[0056] Figure 8 The figure shows the Real-Time PCR test results of HUVEC inoculated on the surface of gelatin-chitosan porous hydrogel microspheres;

[0057] Fig. 9 The cytoskeleton staining image of HUVEC seeded on the surface of gelatin-chitosan porous hydrogel microspheres;

[0058] Fig.10The cell growth distribution diagrams of HUVEC-GFP and MC3T3-E1 loaded on microspheres of two sizes. DETAILED DESCRIPTION

[0059] Methacrylic anhydride: CAS No.: 760-93-0, 276685 Sigma-Aldrich

[0060] Span-80: CAS No.: 1338-43-8, S110840aladdin

[0061] The purchased Penicillin-Streptomycin solution is recorded as the double antibody in this application and is added to the culture medium or DPBS as needed. The double antibody volume used is usually 1%, and the double antibody volume added to the DPBS for partial washing is 2%.

[0062] Lithium Phenyl(2,4,6-trimethylbenzoyl)phosphinate, LAP.

[0063] Double antibody refers to a mixture of penicillin and streptomycin, with the working concentration of penicillin being 100U / ml and the working concentration of streptomycin being 0.1mg / ml.

[0064] To make the present invention more understandable, the present invention will be further described below in conjunction with specific embodiments, but the protection scope of the present invention is not limited thereto. Modifications or replacements to details such as the implementation methods of the present invention without departing from the present invention are all within the protection scope of the present invention.

[0065] Example 1. Preparation of large porous gelatin microspheres

[0066] 1. Preparation method of modified gelatin and modified chitosan

[0067] 1. Modification of gelatin:

[0068] (1) Weigh 10 g of gelatin and dissolve it in 100 mL of 1× PBS;

[0069] (2) Stirring at 400 rpm for 30 min at 50 °C to accelerate dissolution;

[0070] (3) Slowly add 5 mL of methacrylic anhydride and react for 2 h;

[0071] (4) Pour the reaction solution into a dialysis bag with a molecular weight cutoff of 14 kDa and dialyze at 40 °C for 7 days;

[0072] (5) The dialyzed gelatin is freeze-dried to obtain modified gelatin.

[0073] 2. Modification of chitosan:

[0074] (1) Weigh 1.5 g of chitosan and dissolve it in 100 mL of 4% (v / v) glacial acetic acid;

[0075] (2) Stir at room temperature for 12 h to accelerate dissolution;

[0076] (3) Slowly add 6 mL of methacrylic anhydride and stir at 400 rpm for 12 h at 40 °C in the dark;

[0077] (4) Pour the reaction solution into a dialysis bag with a molecular weight cutoff of 14 kDa and dialyze at 40 °C for 7 days;

[0078] (5) The dialyzed chitosan is freeze-dried to obtain modified chitosan.

[0079] Unmodified gelatin has a slow degradation rate and poor mechanical properties, which makes it difficult and challenging to use gelatin to prepare hydrogel bioscaffolds that need to maintain stable morphology and excellent mechanical properties. The modified gelatin not only retains its original characteristics, but also shows better mechanical properties and adjustable physical and chemical properties. The bioscaffolds prepared with it will be more stable, and there are abundant unsaturated photo-crosslinking groups on the surface, which makes it very easy to undergo photoinduced reactions and easier to photocuring. Unmodified chitosan is extremely difficult to dissolve, but the modified chitosan can be dissolved in PBS and given the ability to photocuring, so that gelatin and chitosan can be mixed, and then the two can be mixed evenly through sequential temperature control.

[0080] 2. (1) Weigh 0.3 g of modified gelatin and dissolve it in 3 mL 1× PBS containing 0.5% LAP (photoinitiator). The following photoinitiators can also be used: Irgacure 2959 (I2959) or sodium phenyl (2,4,6-trimethylbenzoyl) phosphite (NAP);

[0081] (2) Dissolve the gelatin solution in a 50°C water bath away from light;

[0082] (3) Weigh 0.06 g of Span-80 into a beaker, add 15 mL of paraffin oil, and mix thoroughly;

[0083] (4) slowly dripping the dissolved prepolymer solution into paraffin oil, stirring at 400 rpm in the dark at 20-22° C. for 30 min, and collecting the W / O emulsion;

[0084] (5) Collect the W / O emulsion at 100 mw / cm 2The light intensity was 405 nm and the blue light was exposed for 5 min for photocuring to obtain large-sized gelatin microspheres.

[0085] (6) Collect the microspheres into a 15 mL centrifuge tube, remove the supernatant after precipitation, and add 5 mL of acetone to wash three times to remove oil;

[0086] (7) Remove acetone as much as possible and add 5 mL of ultrapure water to wash three times to remove acetone;

[0087] (8) The treated microspheres were frozen at -20°C for 30 min, then moved to -80°C for 10 min, and finally placed in liquid nitrogen for 10 min for gradient freezing, and then freeze-dried to obtain large-sized porous gelatin microspheres.

[0088] Figure 2 As shown, the large size refers to the microsphere diameter between 150 and 350 μm without adding emulsifier and only by changing the stirring temperature.

[0089] Example 2. Preparation of small-sized porous gelatin microspheres

[0090] 1. Preparation method of modified gelatin and modified chitosan

[0091] Specific steps are as follows Figure 1 As shown:

[0092] Modification of gelatin:

[0093] (1) Weigh 10 g of gelatin and dissolve it in 100 mL of 1× PBS;

[0094] (2) Stirring at 400 rpm for 30 min at 50 °C to accelerate dissolution;

[0095] (3) Slowly add 5 mL of methacrylic anhydride and react for 2 h;

[0096] (4) Pour the reaction solution into a dialysis bag with a molecular weight cutoff of 14 kDa and dialyze at 40 °C for 7 days;

[0097] (5) The dialyzed gelatin is freeze-dried to obtain modified gelatin.

[0098] 2. (1) Weigh 0.3 g of modified gelatin to a final concentration of 10% and dissolve it in 3 mL of 1× PBS containing 0.5% LAP;

[0099] (2) Dissolve the gelatin solution in a 50°C water bath away from light;

[0100] (3) Weigh 0.01 g of Tween-60 and dissolve it in the gelatin solution to obtain a prepolymer solution;

[0101] (4) Weigh 0.06 g of Span-80 into a beaker and dissolve it in 15 mL of paraffin oil;

[0102] (5) Slowly drip the dissolved prepolymer solution into paraffin oil and stir at 400 rpm in the dark at 20-22°C for 30 min;

[0103] (6) Collect the W / O emulsion at 100 mw / cm 2 The light intensity was 405 nm and the blue light was exposed for 5 min for photocuring to obtain small-sized gelatin microspheres.

[0104] (7) Collect the microspheres into a 15 mL centrifuge tube, remove the supernatant after precipitation, and add 5 mL of acetone to wash three times to remove oil;

[0105] (8) Remove acetone as much as possible and add 5 mL of ultrapure water to wash three times to remove acetone;

[0106] (9) The treated microspheres were frozen at -20°C for 30 min, then moved to -80°C for 10 min, and finally placed in liquid nitrogen for 10 min for gradient freezing, and then freeze-dried to obtain small-sized porous gelatin microspheres.

[0107] Figure 4 The pores of porous microspheres under a scanning electron microscope are shown. The pore size mainly depends on gradient freezing. The pore size is more conducive to cell adhesion and migration. Due to the different freezing points of different materials, continuous attempts are needed to find the appropriate freezing time to achieve the desired pore size effect.

[0108] Figure 2 As shown, the small size refers to the addition of an emulsifier and the control of temperature so that the diameter of the microspheres is between 30-70 μm.

[0109] Example 3. Preparation of gelatin-chitosan composite porous hydrogel microspheres

[0110] 1. Preparation method of modified gelatin and modified chitosan

[0111] 1. Modification of gelatin:

[0112] (1) Weigh 10 g of gelatin and dissolve it in 100 mL of 1× PBS;

[0113] (2) Stirring at 400 rpm for 30 min at 50 °C to accelerate dissolution;

[0114] (3) Slowly add 5 mL of methacrylic anhydride and react for 2 h;

[0115] (4) Pour the reaction solution into a dialysis bag with a molecular weight cutoff of 14 kDa and dialyze at 40 °C for 7 days;

[0116] (5) The dialyzed gelatin is freeze-dried to obtain modified gelatin.

[0117] 2. Modification of chitosan:

[0118] (1) Weigh 1.5 g of chitosan and dissolve it in 100 mL of 4% (v / v) glacial acetic acid;

[0119] (2) Stir at room temperature for 12 h to accelerate dissolution;

[0120] (3) Slowly add 6 mL of methacrylic anhydride and stir at 400 rpm for 12 h at 40 °C in the dark;

[0121] (4) Pour the reaction solution into a dialysis bag with a molecular weight cutoff of 14 kDa and dialyze at 40 °C for 7 days;

[0122] (5) The dialyzed chitosan is freeze-dried to obtain modified chitosan.

[0124] 2. (1) Weigh 0.2 g of modified gelatin to a final concentration of 10% and dissolve it in 2 mL of 1× PBS containing 0.5% LAP;

[0125] (2) Weigh 0.01 g of modified chitosan and dissolve it in 1 mL of 1× PBS containing 0.5% LAP;

[0126] (3) Dissolve the gelatin solution and chitosan solution in a 50°C water bath away from light and mix them;

[0127] (4) Weigh 0.01 g of Tween-60 and dissolve it in the mixed solution, the total liquid is 3 ml, and a prepolymer solution is obtained;

[0128] (5) Weigh 0.06 g of Span-80 into a beaker and dissolve it in 15 mL of paraffin oil;

[0129] (6) Slowly drip the dissolved prepolymer solution into paraffin oil and stir at 400 rpm in the dark at 20-22°C for 30 min;

[0130] (7) Collect the W / O emulsion at 100 mw / cm 2 The light intensity was 405 nm and the blue light was exposed for 5 min for photocuring to obtain small-sized gelatin microspheres.

[0131] (8) Collect the microspheres into a 15 mL centrifuge tube, remove the supernatant after precipitation, and add 5 mL of acetone to wash three times for degreasing;

[0132] (9) Remove acetone as much as possible and add 5 mL of ultrapure water to wash three times to remove acetone;

[0133] (10) The treated microspheres were frozen at -20°C for 30 min, then moved to -80°C for 10 min, and finally placed in liquid nitrogen for 10 min for gradient freezing, and then freeze-dried to obtain gelatin-chitosan composite porous hydrogel microspheres.

[0134] For this embodiment, composite microspheres can still be successfully prepared after weighing 0.02g of modified chitosan and dissolving it in 1mL1×PBS containing 0.5% LAP. However, when weighing 0.03g of modified chitosan and dissolving it in 1mL1×PBS containing 0.5% LAP, chitosan is not easily soluble. Considering that the chitosan solution has reached saturation, subsequent experiments cannot be carried out.

[0135] If the content of methacrylic anhydride modified gelatin is less than 10%, the water content of the microspheres is high and the microsphere morphology is easily destroyed during the stirring process. If it is greater than 20%, the loading capacity of the formed microspheres for cells is significantly reduced.

[0136] If the Tween-60 content is less than 0.3%, the emulsion formed is unstable and the obtained microspheres are large in size. If it is greater than 3%, the obtained microspheres are not easy to disperse and independent microspheres cannot be obtained.

[0137] If the Span-80 content is less than 0.1%, the formed emulsion is unstable and the obtained microspheres are large in size. If it is greater than 0.4%, the obtained microspheres are not easily dispersed and independent microspheres cannot be obtained.

[0138] If the temperature is lower than 20°C, the rotation speed is lower than 400 rpm, and the time is lower than 30 min, the obtained microspheres will not be transparent. If the temperature is higher than 22°C, higher than 1000 rpm, and the time is higher than 60 min, the obtained microspheres will not be easily dispersed, independent microspheres cannot be obtained, and bubbles are easily generated during the stirring process.

[0139] If the light curing time is less than 30 seconds, the microspheres cannot be formed; if the light curing time is greater than 5 minutes, the microspheres are too hard;

[0140] If the liquid nitrogen treatment time is less than 5 minutes, the pore size is too small; if it is more than 10 minutes, the microspheres will be broken.

[0141] like Figure 3 As shown, without gradient freezing, no pores were made on the surface of the microspheres, and after gradient freezing, pores were successfully made on the surface of the microspheres;

[0142] Figure 2 As shown, the small size refers to the addition of an emulsifier and the control of temperature so that the diameter of the microspheres is between 20-50 μm.

[0143] Example 4. Preparation of single cell microspheres

[0144] (1) Weigh 1 portion of 4 mg of microspheres from Example 1 and 3 portions of 4 mg of microspheres from Example 3 into a 2 mL EP tube;

[0145] (2) Place it under a clean bench and irradiate it with ultraviolet light for 1 hour to sterilize it;

[0146] (3) Wash three times with DPBS containing 2% double antibody;

[0147] (4) Wash three times with cell culture medium;

[0148] (5) The microspheres were mixed with 1×10 5 C2C12 (mouse myoblasts), MAC-T (bovine mammary epithelial cells), and MC3T3-E1 (mouse embryonic osteoblast precursor cells) cell suspensions were mixed and incubated for 3 hours (MC3T3-E1 was mixed with the microspheres of Example 1, and the other two cells were mixed with the microspheres of Example 3);

[0149] (6) After the microspheres and cells are fully adhered, they are transferred to a 24-well plate;

[0150] (7) Place in a constant temperature incubator at 37°C and 5% CO2 and continue culturing;

[0151] (8) After 1 day of culture, observe whether the microspheres can support the growth of different cell types.

[0152] Figure 5 The cell adhesion is shown. Through fluorescence microscopy, it was found that a large number of cells adhered and grew on the microspheres. It can be observed that the MAC-T cell morphology is dot-shaped, the C2C12 cells are typical fibroblast-like, and the cell shape is long. The MC3T3-E1 cells are long and spindle-shaped. All three cells are similar to the extended morphology when cultured on the well plate. In addition, the microspheres can be connected through cells, indicating that the microspheres can support the 3D culture of a variety of cells and are very potential cell microcarriers. Large-diameter microspheres can adhere to more cells, which is conducive to the extension of cell morphology. The cell morphology on the microspheres is similar to that of the cells when they grow on the plane, indicating that the microspheres can support the simultaneous growth of multiple cells. Both types of cell distribution can be observed on the same microsphere, and the overall number is comparable, with no obvious difference. Under low-power microscopes, a large number of cells can be observed growing on the microspheres. The microspheres are tightly connected, which can achieve cell co-culture, thereby better simulating the microenvironment in vivo.

[0153] Example 5. Testing biocompatibility

[0154] Cell live and dead staining kit was used to stain the cell-loaded microspheres

[0155] (1) Weigh 1 mg of the microspheres prepared in Example 2 into a 2 mL EP tube;

[0156] (2) Place it under a clean bench and irradiate it with ultraviolet light for 1 hour to sterilize it;

[0157] (3) Wash three times with DPBS containing 2% double antibody;

[0158] (4) Wash three times with endothelial-specific culture medium;

[0159] (5) The microspheres were mixed with 1×10 5 The HUVEC cell suspension of 10 cells was mixed and incubated for 3 h;

[0160] (6) After the microspheres and cells are fully adhered, they are transferred to a 24-well plate;

[0161] (7) Place in a constant temperature incubator at 37°C and 5% CO2 and continue culturing;

[0162] (8) After 48 h of culture, the culture medium was removed, the cells were stained with ELISA, and photographed under a fluorescence microscope.

[0163] Figure 6 The results of cell live and dead staining are shown, with live cells in green and dead cells in red. By comparing the light microscope image with the fluorescence image, it can be observed that a large number of live cells grow on the surface of the microspheres, accounting for nearly 70% of the surface of the microspheres, and almost no dead cells are observed, indicating that the microspheres have good biocompatibility. In addition, when the experiment is carried out using Example 1 and Example 3, the same results can be obtained.

[0164] Example 6. Detection of promotion of cell proliferation

[0165] CCK-8 kit was used to detect the effect of microspheres on HUVEC cell activity

[0166] (1) Weigh 0.1 mg of the microspheres prepared in Example 3 into a 2 mL EP tube;

[0167] (2) Place it under a clean bench and irradiate it with ultraviolet light for 1 hour to sterilize it;

[0168] (3) Wash three times with DPBS containing 2% double antibody;

[0169] (4) Wash three times with endothelial-specific culture medium;

[0170] (5) The microspheres were mixed with 5×10 4 The HUVEC cell suspension of 10 cells was mixed and incubated for 3 h;

[0171] (6) After the microspheres and cells are fully adhered, they are transferred to a 96-well plate;

[0172] (7) Place in a constant temperature incubator at 37°C and 5% CO2 and continue culturing;

[0173] (8) CCK-8 reagent was added for detection after 0, 1, 3, 5 and 7 days of culture, wherein the experimental group was the composite microspheres and the control group was the microspheres of Example 2.

[0174] like Figure 7 As shown, the composite microspheres show the effect of promoting cell proliferation. The blue color is the data of the microspheres in Example 2, and the red color is the data of the microspheres in Example 3. The results show that as the culture time increases, the number of cells in all groups shows an increasing trend. In the early stage of culture (0 days and 1 day), there is no significant difference in the cell viability of the microspheres in Example 3 and the microspheres in Example 2. On the 3rd day, the cell proliferation rate of the microspheres in Example 3 accelerated, and the cell viability exceeded that of Example 2 by as much as 80%. On the 5th and 7th days, the cell viability of the microspheres in Example 3 was still about 20% higher than that of the microspheres in Example 2, indicating that the composite microspheres have good biocompatibility and significantly promote cell proliferation, proving that it is meaningful to compound the materials. In the live-dead staining results, green represents live cells and red represents dead cells. As can be seen from the figure, there are almost no dead cells, proving that there is no cytotoxicity and good biocompatibility. In addition, we also conducted the above experiment on the composite microspheres prepared using 2% chitosan. On the third day, the cell viability of the microspheres exceeded that of Example 2 by nearly 110%, and on the 5th and 7th days, it also exceeded that of Example 2.

[0175] Example 7. Detection of vascular-related gene expression in microsphere cultured cells by qPCR

[0176] (1) Weigh 4 mg of the microspheres in Example 2 and Example 3 respectively into a 2 mL EP tube;

[0177] (2) Place it under a clean bench and irradiate it with ultraviolet light for 1 hour to sterilize it;

[0178] (3) Wash three times with DPBS containing 2% double antibody;

[0179] (4) Wash three times with endothelial-specific culture medium;

[0180] (5) The microspheres were mixed with 2×10 5 The HUVEC cell suspensions were mixed and incubated for 3 h;

[0181] (6) After the microspheres and cells are fully adhered, they are transferred to a 6-well plate, and the HUVEC cells cultured on the plate are used as a control group and placed in a constant temperature incubator at 37°C and 5% CO2 for further culture;

[0182] (7) After 5 days of culture, discard the culture medium;

[0183] (8) After washing three times with DPBS, the cells were collected into an enzyme-free EP tube, 1 mL of Trizol was added, and the cells were repeatedly pipetted;

[0184] (9) Vortex the sample for 2 min and then let it stand at 20-22°C for 5 min;

[0185] (10) Add 200 μL of chloroform, vortex for 2 min, and let stand at room temperature for 5 min;

[0186] (11) Centrifuge at 12,000 g for 15 min at 4°C;

[0187] (12) Take the upper aqueous phase and add it to a new 1.5 mL EP tube;

[0188] (13) Add 500 μL of isopropanol and 2 μL of LycoBlue TM The coprecipitate was gently mixed and briefly centrifuged;

[0189] (14) Sedimentation at -20°C for more than 1 hour;

[0190] (15) Centrifuge at 12,000 g for 15 min at 4°C;

[0191] (16) Remove the supernatant, take 1 mL of freshly prepared 75% ethanol to reprecipitate, and repeat centrifugation to discard the supernatant to remove the ethanol;

[0192] (17) After standing for 3-5 min, dissolve the RNA in 30 mL of enzyme-free water and heat at 55 °C for 10 s to aid dissolution, thereby obtaining an RNA solution.

[0193] (18) The extracted RNA was reverse transcribed according to the system in Table 1 to obtain cDNA, wherein the reverse transcription conditions were: 10 min at 25°C; 120 min at 37°C; 5 min at 85°C;

[0194] (19) Real-Time PCR was performed using the cDNA obtained by reverse transcription to detect the expression of angiogenic genes and evaluate its ability to promote angiogenesis. The reaction system is shown in Table 2 and the primers are shown in Table 3.

[0195] Figure 8The results of Real-Time PCR detection are shown in Table 3. The primer sequences are shown in Table 3, indicating that compared with the microspheres in Example 2 of a single material, the microspheres in Example 3 significantly increased the expression of vascular-related genes VEGF and ANG, and the expression of the three genes was stronger than that in 2D culture (HUVEC and HUVEC-GFP used endothelial cell-specific culture medium purchased from Anwei Bio; C2C12 and MAC-T used DMEM culture medium purchased from GIBCO; MC3T3-E1 used α-MEM culture medium purchased from GIBCO). When the experiment was carried out using composite microspheres prepared with 2% chitosan, the results were similar, and the expression of KDR was also promoted.

[0196] Table 1

[0197] Element Volume (μL) 10x RT buffer 3.0 20x dNTP Mix 1.2 RT Random Primers 3.0 MultiScribe™ Reverse Transcriptase 1.5 Nuclease-free H2O 6.3 RNA template 15.0 Total volume 30.0

[0198] Table 2 The PCR amplification procedure is as follows:

[0199] (1) Pre-denaturation 95℃30s, Reps: 1

[0200] (2) PCR reaction: 95°C for 5 s, 60°C for 34 s, Reps: 40

[0201] Table 3

[0202]

[0203]

[0204] Example 8.

[0205] FITC-phalloidin and Hoechst33342 were used to observe the cell morphology on the microsphere surface

[0206] (1) Weigh 4 mg of the microspheres prepared in Example 3 into a 2 mL EP tube;

[0207] (2) Place it under a clean bench and irradiate it with ultraviolet light for 1 hour to sterilize it;

[0208] (3) Wash three times with DPBS containing 2% double antibody;

[0209] (4) Wash three times with endothelial-specific culture medium;

[0210] (5) with 1×10 5 The HUVEC cell suspension of 10 cells was mixed and incubated for 3 h;

[0211] (6) After the microspheres and cells are fully adhered, they are transferred to a 24-well plate;

[0212] (7) Place in a constant temperature incubator at 37°C and 5% CO2 and continue culturing;

[0213] (8) After 2 days of culture, the culture medium was removed and the cells were washed three times with DPBS preheated at 37°C, each time for 10 min.

[0214] (9) Add 1 mL of 4% paraformaldehyde to each well and fix overnight at 4°C;

[0215] (10) After fixation, wash with DPBS three times, leaving for 10 min each time;

[0216] (11) Add 1 mL of 1% Triton X-100 solution to each well for permeabilization for 1 h;

[0217] (12) Wash with DPBS three times, leaving for 10 min each time;

[0218] (13) Add 1 mL of FITC-phalloidin working solution to each well and incubate at room temperature in the dark for 1 h;

[0219] (14) Wash three times with DPBS, leaving for 10 min each time;

[0220] (15) Add 1 mL of 1% Hoechst 33342 to each well and incubate at room temperature in the dark for 5 min;

[0221] (16) Wash three times with DPBS, leaving for 10 min each time;

[0222] (17) Observe the samples using a fluorescence microscope.

[0223] Fig. 9 The localization map of HUVEC cytoskeleton and nucleus on the surface of microspheres was displayed. The results showed that HUVEC cells could form tight cell-loaded microsphere aggregates with microspheres, and a large number of cytoskeleton aggregates, and adjacent microspheres were tightly connected by a large number of stretched cells, further proving that microspheres can support cell attachment and growth on their surface.

[0224] Example 9. Preparation of multicellular microspheres

[0225] (1) Culture HUVEC-GFP (human umbilical vein endothelial cells) (purchased from Shanghai Anwei Biotechnology Co., Ltd.) and MC3T3-E1 cells respectively;

[0226] (2) When the cells grow to 70-80%, the cells are digested and labeled with Mito-Tracker Red tracer (after digesting the cells, add Mito-Tracker Red working solution and incubate for 15-45 minutes before labeling, remove the working solution and add culture medium for subsequent experiments);

[0227] (3) Weigh 2 mg of the microspheres prepared in Example 1 and 2 mg of the microspheres prepared in Example 3 into a 2 mL EP tube;

[0228] (4) Place it under a clean bench and irradiate it with ultraviolet light for 1 hour for sterilization;

[0229] (5) Wash three times with DPBS containing 2% double antibody;

[0230] (6) Wash three times with cell culture medium;

[0231] (7) The treated microspheres were mixed with 1×10 HUVEC-GFP and MC3T3-E1 5 The mixed cell suspension was incubated for 3 h;

[0232] (8) After the microspheres and cells are fully adhered, they are transferred to a 12-well plate;

[0233] (9) Place in a constant temperature incubator at 37°C and 5% CO2 for continued cultivation;

[0234] (10) After 48 h of culture, the cell distribution was observed under a fluorescence microscope.

[0235] Fig.10 The distribution of the two types of cells was demonstrated. The results showed that both types of cells were evenly distributed on the same microsphere, with similar overall numbers and no significant differences. Under a low-power microscope, a large number of cells could be observed growing on the microspheres. The microspheres were tightly connected, allowing cell co-culture to better simulate the in vivo microenvironment.

Claims

1. A method for preparing composite porous hydrogel microspheres based on sequential temperature control, characterized in that: The specific steps of the preparation method are as follows: Step 1: Weigh methacrylic anhydride-modified gelatin and dissolve it in 1×PBS containing 0.5%-2% by volume of photoinitiator to obtain a gelatin solution with a final concentration of 10%-20%; Step 2: weigh methacrylic anhydride-modified chitosan, and dissolve it in 1×PBS containing 0.5%-2% by volume of a photoinitiator to obtain a chitosan solution with a final concentration of 1%-2%; Step 3: placing the gelatin solution obtained in step 1 and the chitosan solution obtained in step 2 in a 37-50° C. water bath away from light and mixing to obtain a mixed solution; Step 4: dissolving the emulsifier in the mixed solution obtained in step 3 to obtain a prepolymer solution with a final emulsifier concentration of 0.3% to 3%; Step 5: dissolving the emulsifier in paraffin oil to obtain an oil phase solution containing 0.1%-0.4% of the emulsifier; Step 6: Add the prepolymer obtained in step 4 to the oil phase solution obtained in step 5 at a rate of 0.1-1 mL / min, and stir at 400-1000 rpm in the dark for 30-60 min at 20-22°C to obtain a W / O emulsion with a concentration of 100 mw / cm 2 The light intensity was set to 405 nm, and the resulting gelatin microspheres were exposed to 405 nm blue light for 30 s to 5 min for photocuring. Step 7: Degrease the microspheres obtained in step 6, freeze them at -20°C for 0-30 min, then move them to -80°C for 0-10 min, and finally quickly freeze them in liquid nitrogen for 5-10 min for gradient freezing to obtain gelatin-chitosan composite porous hydrogel microspheres.

2. The preparation method according to claim 1, characterized in that: The method for obtaining methacrylic anhydride modified gelatin in step 1 is as follows: (1) Weigh 10 g of gelatin and dissolve it in 100 mL of 1× PBS; (2) Stirring at 400 rpm for 30 min at 50 °C to accelerate dissolution; (3) Slowly add 5 mL of methacrylic anhydride and react for 2 h; (4) Pour the reaction solution into a dialysis bag with a molecular weight cutoff of 14 kDa and dialyze at 40 °C for 7 days; (5) The dialyzed gelatin is freeze-dried to obtain modified gelatin.

3. The preparation method according to claim 1, characterized in that: Step 2 The method for obtaining methacrylic anhydride modified chitosan is as follows: (1) Weigh 1.5 g of chitosan and dissolve it in 100 mL of 4% (v / v) glacial acetic acid; (2) Stir at room temperature for 12 h to accelerate dissolution; (3) Slowly add 6 mL of methacrylic anhydride and stir at 400 rpm for 12 h at 40 °C in the dark; (4) Pour the reaction solution into a dialysis bag with a molecular weight cutoff of 14 kDa and dialyze at 40 °C for 7 days; (5) The dialyzed chitosan is freeze-dried to obtain modified chitosan.

4. The preparation method according to claim 1, characterized in that: The photoinitiator is LAP.

5. The preparation method according to claim 1, characterized in that: The emulsifier is Tween-60 or Span-80.

6. The preparation method according to claim 1, characterized in that: The degreasing method in step 7 is to add 5 mL of acetone and wash three times.

7. Gelatin-chitosan composite porous hydrogel microspheres obtained by the preparation method according to any one of claims 1 to 6.

8. Use of the gelatin-chitosan composite porous hydrogel microspheres according to claim 7 in the preparation of biological scaffolds for non-diagnosis and treatment purposes.

9. Use of the gelatin-chitosan composite porous hydrogel microspheres according to claim 7 in cultured cells for non-diagnosis and treatment purposes.

10. Use of the gelatin-chitosan composite porous hydrogel microspheres according to claim 7 in promoting angiogenesis or promoting osteogenic differentiation for non-diagnostic and non-therapeutic purposes.

Citation Information

Cited By

  • Enzyme polymer composite composition and application thereof

    CN122005907A